CNMD - CONMED - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CNMD is currently covered by 8 analysts with an average price target of $81.77. This is a potential upside of $14.08 (20.8%) from yesterday's end of day stock price of $67.69.

CONMED's activity chart (see below) currently has 115 price targets and 104 ratings on display. The stock rating distribution of CNMD is 88.24% BUY and 11.76% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.03% with an average time for these price targets to be met of 161.73 days.

Highest price target for CNMD is $98, Lowest price target is $75, average price target is $81.77.

Most recent stock forecast was given by MIKE MATSON from NEEDHAM on 31-Oct-2024. First documented stock forecast 16-Jan-2015.

Currently out of the existing stock ratings of CNMD, 30 are a BUY (88.24%), 4 are a HOLD (11.76%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$97

$28.18 (40.95%)

$97

2 months 17 days ago
(31-Oct-2024)

22/34 (64.71%)

$28.76 (42.15%)

226

Buy

$76

$7.18 (10.43%)

$120

5 months 16 days ago
(01-Aug-2024)

11/14 (78.57%)

$10.66 (16.31%)

166

Buy

$80

$11.18 (16.25%)

$100

5 months 16 days ago
(01-Aug-2024)

15/20 (75%)

$14.66 (22.44%)

221

Buy

$75

$6.18 (8.98%)

$115

8 months 23 days ago
(25-Apr-2024)

3/6 (50%)

$13.27 (21.50%)

186

Hold

$98

$29.18 (42.40%)

$107

11 months 16 days ago
(01-Feb-2024)

2/3 (66.67%)

$14.66 (17.59%)

20

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CNMD (CONMED) average time for price targets to be met?

On average it took 161.73 days on average for the stock forecasts to be realized with a an average price target met ratio 67.03

Which analyst has the current highest performing score on CNMD (CONMED) with a proven track record?

MATT O'BRIEN

Which analyst has the most public recommendations on CNMD (CONMED)?

Matt O'brien works at PIPER SANDLER and has 5 price targets and 5 ratings on CNMD

Which analyst is the currently most bullish on CNMD (CONMED)?

Matthew Mishan with highest potential upside - $72.18

Which analyst is the currently most reserved on CNMD (CONMED)?

Matthew Taylor with lowest potential downside - -$15.85

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?